Medtronic said Monday it received 510 (k) clearance from the Food and Drug Administration for an app to connect its smart ...

ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...

The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes.

Weekly insulin dose aces phase 3 trials for easier diabetes management By Michael Irving October 30, 2023 A once-a-week insulin shot has shown promise in a phase three clinical trial Depositphotos ...

The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...

Lyumjev (insulin lispro-aabc) is prescribed to manage blood sugar levels in certain people with type 1 or 2 diabetes. The drug comes as a liquid solution for injection as directed by your doctor. The ...

A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced ...

USA: In a post hoc analysis of the ADJUST-T1D trial, adults with type 1 diabetes receiving once-weekly semaglutide 1 mg showed a significant reduction in total daily insulin dose by 4 weeks, ...

Afrezza (insulin human) is prescribed to help manage blood sugar in adults with diabetes. The drug comes as powder with a cartridge and device for inhaling. You take it at the beginning of each meal.

Insulin use in gestational diabetes presents challenges; education and support are key to overcoming fears and ensuring ...